Companies: 10,795·Total market cap: $144.5T

BetterLife Pharma Inc.

BetterLife Pharma Inc.

BETRFOTCHealthcare● Active

$0.04

+$0.00(+5.16%)

Market Cap$7248058

P/E Ratio—

52W High$0.078

52W Low$0.028

Avg Volume23K

Open$0.04

Beta0.43

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

BetterLife Pharma Inc.（BETRF）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · BETRF · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.01Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding145.9MShares outstanding history

Next EarningsTBAEarnings history

探索 BetterLife Pharma Inc. 数据

分析师预测—

股息不分红

盈利EPS $-0.01+64.08%

财务快照

FY 2026Revenue$0.00

202420252026

FY 2026Net Income-$1.5M▲ +57.45% YoY

202420252026

FY 2026EPS$-0.01▲ +64.08% YoY

202420252026

TTM:Revenue: $0.00Net Income: -$1.5MEPS: $-0.01View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

BetterLife Pharma Inc.

$0.04+5.16%$7.2M #2

Bioxytran, Inc.

$0.03-1.95%$3.4M #3

Burzynski Research Institute, Inc.

$0.01+15.58%$1.4M #4

Chimeric Therapeutics Limited

$0.10+0.00%$4.1M #5

Mosaic ImmunoEngineering Inc.

$0.69+3.03%$5.0M #6

Curative Biotechnology, Inc.

$1.55-1.90%$10.6M

股票表现

1D+5.16%

1W+8.74%

1M-1.32%

3M-9.95%

YTD+38.70%

1Y-39.62%

5Y-81.33%

关于 BetterLife Pharma Inc.

CEOAhmad Doroudian

IPO DateSep 1, 2010

Employees7

CountryCA

Websiteabetterlifepharma.com

BetterLife Pharma Inc. a biotechnology firm headquartered in Vancouver, Canada, specializes in researching and bringing to market therapeutic compounds designed to address neurological disorders acro…

Biotechnology HealthcareOTCCA

关于股票概览与关键数据

BetterLife Pharma Inc.（BETRF）是 Biotechnology 行业的 Healthcare 类公司，于 Sep 1, 2010 在 OTC 上市。截至最近交易日，BETRF 股价为 $0.04，市值约为 $7.2M。过去12个月累计回报 -39.62%，年初至今回报 +38.70%。

2026 财年 BetterLife Pharma Inc. 营收 —。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，BetterLife Pharma Inc.（BETRF）股价为 $0.04，在 OTC 上市，52周区间为 $0.03 – $0.08。

BETRF 最新股价BETRF quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议